NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 77 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,862,931 | $46,355,000 | 3.30% |
| Opaleye Management Inc. | 1,386,300 | $16,636,000 | 3.25% |
| Fairmount Funds Management LLC | 372,748 | $4,473,000 | 1.90% |
| Redmile Group, LLC | 4,172,686 | $50,072,000 | 0.92% |
| Boxer Capital, LLC | 1,501,058 | $18,013,000 | 0.62% |
| Prosight Management, LP | 66,376 | $797,000 | 0.38% |
| HighVista Strategies LLC | 39,234 | $471,000 | 0.34% |
| Baker Brothers Advisors | 3,821,740 | $45,861,000 | 0.18% |
| Granahan Investment Management | 296,511 | $3,558,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $460,000 | 0.09% |